XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   71,618,000        
Beginning balance at Dec. 31, 2022 $ 1,607,775 $ 7,162 $ 1,377,802 $ 423,863 $ (13,019) $ (188,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 30,427     11,827   18,600
Stock based compensation expense 2,642   2,642      
Common stock transactions related to stock based employee benefit plans (in shares)   199,000        
Common stock transactions related to stock based employee benefit plans 3,617 $ 20 3,691   (94)  
Issuance of common stock, pursuant to acquisitions (in shares)   12,792,000        
Issuance of common stock, pursuant to acquisitions 410,738 $ 1,279 409,459      
Conversion of options, pursuant to acquisition 10,304   10,304      
Dividends on common stock (14,419)     (14,419)    
Increase (decrease) in shares during period (in shares)   12,991,000        
Increase (decrease) in stockholders' equity during period 443,309 $ 1,299 426,096 (2,592) (94) 18,600
Ending balance (in shares) at Mar. 31, 2023   84,609,000        
Ending balance at Mar. 31, 2023 $ 2,051,084 $ 8,461 1,803,898 421,271 (13,113) (169,433)
Beginning balance (in shares) at Dec. 31, 2023 84,861,498 84,861,000        
Beginning balance at Dec. 31, 2023 $ 2,108,086 $ 8,486 1,808,883 467,305 (16,710) (159,878)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 21,928     26,006   (4,078)
Stock based compensation expense 2,217   2,217      
Common stock transactions related to stock based employee benefit plans (in shares)   74,000        
Common stock transactions related to stock based employee benefit plans 813 $ 8 841   (36)  
Dividends on common stock (15,294)     (15,294)    
Increase (decrease) in shares during period (in shares)   74,000        
Increase (decrease) in stockholders' equity during period $ 9,664 $ 8 3,058 10,712 (36) (4,078)
Ending balance (in shares) at Mar. 31, 2024 84,935,054 84,935,000        
Ending balance at Mar. 31, 2024 $ 2,117,750 $ 8,494 $ 1,811,941 $ 478,017 $ (16,746) $ (163,956)